U.S. court extends Indivior's restraining order against Dr. Reddy's generic drug

(Reuters) - British drugmaker Indivior Plc said on Friday a U.S. court extended the restraining order blocking Indian pharmaceutical firm Dr.Reddy's Laboratories from launching a generic version of its bestselling opioid addiction treatment in the United States.